✦ LIBER ✦

ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

✍ Scribed by Mallion, J M; Siche, J P; Lacourcière, Y

Book ID: 110048046
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 87 KB
Volume: 13
Category: Article
ISSN: 0950-9240
DOI: 10.1038/sj.jhh.1000925

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised, double-blind comparison of

A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension

✍ Mimran, A; Ruilope, L; Kerwin, L; Nys, M; Owens, D; Kassler-Taub, K; Osbakken, M 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 61 KB

Effect of the angiotensin II receptor bl

Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension

✍ T. Skurk; Y.-M. Lee; T.-O. Nicuta-Rölfs; B. Haastert; A. Wirth; H. Hauner 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Efficacy and Safety of DALI-LDL-Apheresi

Efficacy and Safety of DALI-LDL-Apheresis in Two Patients Treated with the Angiotensin II-Receptor 1 Antagonist Losartan

✍ Thomas Bosch; Thorsten Wendler 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Comparison of the renal effects of dilev

Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension

✍ T. Baba; S. Murabayashi; T. Tomiyama; K. Takebe 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 339 KB

The effects of 6 weeks of treatment with dilevalol 100 mg once daily, or carteolol 10 mg once daily, on renal blood flow (RBF), glomerular filtration rate (GFR) and total renal vascular resistance (TRR) were studied in 10 patients with mild-to-moderate essential hypertension in a randomised cross-ov

Proceedings of the Symposium ‘Angiotensi

Proceedings of the Symposium ‘Angiotensin AT1 Receptors: From Molecular Physiology to Therapeutics’: EXPERIENCE WITH ANGIOTENSIN II ANTAGONISTS IN HYPERTENSIVE PATIENTS

✍ Bernard Waeber; Michel Burnier; Jürg Nussberger; Professor Hans R Brunner 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

A randomised, double-blind, double-dummy

A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension

✍ James, I G V; Jones, A; Davies, P 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB